BibbInstruments (BIBB.SL) Aktie Kurs

BiBBInstruments AB is a medical technology company, which engages in developing and marketing of diagnostic instruments for early detection of cancerous tumors. The company is headquartered in Lund, Skane and currently employs 4 full-time employees. The company went IPO on 2017-10-27. The company develops and sales biopsy instruments, which are based on technology platform EndoDrill. The drill function enables early cancer diagnosis, especially in deep skin tissues. The portfolio includes EndoDrill GI Upper for stomach biopsy, EndoDrill GI Lower for intestinal biopsy, EndoDrill GI Lung for lung biopsy, EndoDrill Therapy to pass displacements in different organs for placement of conductors, balloons and stents for treatment, EndoDrill Needle for breasts biopsy, as well as EndoDrill Model X for multiple areas and falls under independent research project. Products are distributed to hospitals with endoscopy specialists’ centers and surgical wards. The Company’s primary distribution focus is Scandinavian countries.